Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.
PURPOSE: We previously reported that a panel of four kallikrein forms in blood-total, free, and intact prostate-specific antigen (PSA) and kallikrein-related peptidase 2 (hK2)-can reduce unnecessary biopsy in previously unscreened men with elevated total PSA. We aimed to replicate our findings in a...
Autores principales: | Vickers, A, Cronin, A, Roobol, M, Savage, C, Peltola, M, Pettersson, K, Scardino, P, Schröder, F, Lilja, H |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2010
|
Ejemplares similares
-
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.
por: Gupta, A, et al.
Publicado: (2010) -
A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
por: Vickers, A, et al.
Publicado: (2010) -
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
por: Vickers, A, et al.
Publicado: (2008) -
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.
por: Benchikh, A, et al.
Publicado: (2010) -
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.
por: Vickers, A, et al.
Publicado: (2011)